Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein

201666 citationsJournal Articlegold Open Access

Authors

Didymin alleviates hepatic fibrosis by inhibiting ERK/MAPK and PI3K/Akt pathways via regulation of RKIP expression.

Good health and well-being

Published in: Cellular Physiology and Biochemistry

Volume 40, Issue 6, pp. 1422-1432

Field-Weighted Citation Impact: 5.44